Only losing 1lb a week on Mounjaro — here's what that actually means

You've been on Mounjaro a few weeks and the scales barely moved

Picture this: two weeks in, you step on the scales expecting something dramatic and the number is down by a pound. Maybe a pound and a half. Friends on GLP-1 medicines seem to be posting bigger losses online, and you're wondering whether something is wrong. Probably nothing is. Mounjaro starts at 2.5mg, a dose whose main job is getting your system adjusted, not producing rapid loss. The therapeutic effect builds as the dose increases, which is why the trial data shows heavier losses accumulating over months rather than in the first fortnight.

In SURMOUNT-1, published in the New England Journal of Medicine, participants at the highest dose lost around 20–21% of body weight on average over 72 weeks, but that average conceals enormous week-to-week variation. A pound in one week followed by three in the next is common. Comparing your week two to someone else's week ten is comparing entirely different points on the curve. If you've recently moved up a dose, give it four to six weeks before drawing conclusions about whether the new level is working.

One quick habit worth building: weigh yourself at the same time of day, on the same day each week, without clothes, after using the bathroom. That single consistency removes most of the noise. A five-day average tells you even more than a single weekly weigh-in.

For a broader picture of what progress looks like across the treatment, the guide on losing weight on Mounjaro walks through what realistic expectations look like at each stage.

Why some people see slower loss at the same dose

Even at an established dose, losing around 1lb a week on Mounjaro is not unusual, and several factors explain why two people on the same 5mg or 7.5mg pen can see different results. Starting weight matters: a heavier starting point means a pound represents a smaller percentage reduction, even if absolute fat loss is identical. Metabolic adaptation is real too, your body becomes more efficient at lower calorie intakes over time, which is partly why dose increases tend to restart movement on the scales.

Food choices shift the picture significantly. Tirzepatide reduces appetite and slows gastric emptying, but it doesn't override energy intake entirely. People who find their appetite returning between injections, or who have shifted to eating smaller amounts of energy-dense foods rather than genuinely lower-calorie meals, often see slower loss. Protein intake is worth watching: inadequate protein can mean some of the weight lost is lean mass rather than fat, which both slows visible results and affects how you feel.

Sleep and stress affect the hormones that govern fat storage. This isn't a motivation lecture, it's physiology. Poor sleep raises cortisol and ghrelin, both of which work against the appetite-suppression that tirzepatide provides. If your sleep has been disrupted and your weekly loss has slowed, that's a plausible connection. The NHS patient information page for tirzepatide covers what to expect from the medicine and when to contact your prescriber. Medication reviews (including whether your dose should be reviewed) are exactly what aftercare is for.

When slower loss is a signal worth acting on

There's a difference between a slow week and a pattern. If you find yourself only losing 1 pound a week on Mounjaro consistently over six to eight weeks, while eating a reduced-calorie diet and moving more, it might mean it's time to discuss a dose review with your prescriber. NICE's guidance on tirzepatide notes that continuing treatment should be reviewed if weight loss is less than 5% after six months at the highest tolerated dose, so sustained slow progress at a lower dose is a reasonable thing to flag before that point.

It's also worth checking whether any other medicines you take could be interfering. Some antidepressants, antipsychotics, corticosteroids and insulin-related treatments affect weight regulation. This is a prescriber conversation, not a self-adjustment. Similarly, untreated hypothyroidism or insulin resistance can blunt loss even on an effective GLP-1 medicine, conditions a prescriber can screen for if they haven't already.

What slower loss is almost never a sign of is that the medicine isn't working at all. The clinical picture is rarely that simple. A week of 1lb might be followed by three or four weeks that look very different. If you're uncertain about your progress and wondering whether the treatment is right for you, you can explore your options on the weight-loss treatments page, or read more about how tirzepatide works as a medicine on the tirzepatide overview.

One thing that catches people off guard: hair shedding in the first few months of treatment. It's linked to the physiological stress of rapid calorie reduction rather than the medicine itself, and it's temporary. If that's something you've noticed alongside slower-than-expected scale movement, the page on losing hair on Mounjaro explains the mechanism and what typically helps.

What to do if you're unsure whether your progress is on track

The most useful thing you can do is talk to your prescriber. Not because slow loss is a crisis (it almost certainly isn't) but because a clinical review can identify whether a dose adjustment is appropriate, whether any other factors are at play, and whether your current trajectory is broadly in line with what the medicine is expected to produce at your dose and duration. That context is genuinely hard to assess from the scales alone.

At nume, every repeat order goes through a clinical review by a GPhC-registered prescriber before anything is dispensed. That review exists precisely for conversations like this one. If you have questions about your progress, cost context, or how private treatment works, the Mounjaro price comparison guide sets out what to look for in a legitimate private provider, and our FAQs cover many of the practical questions that come up during treatment.

Losing around a pound a week isn't failure. For many people, it's the medicine working steadily, at the pace their body allows. If you'd like a prescriber to look at the full picture, start your free consultation and get a same-day clinical review from one of our team.